Exact Mass: 457.2377
Exact Mass Matches: 457.2377
Found 500 metabolites which its exact mass value is equals to given mass value 457.2377
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
10,11-Dihydro-12R-hydroxy-leukotriene E4
10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
CENTCHROMAN
(3S*,3aR*,5R*,5aS*,6S*,10aR*,11R*,12aS*,12bS*)-5-acetoxy-5a-(acetoxymethyl)-2,3,3a,5,5a,6,7,8,9,10,10a,11,12,12b-tetradecahydro-3-methyl-4H-1,6-methanocyclopent[1,8]azuleno[4,3a-g]indole-11-carboxylic acid|macropodumine H
12-seco-14-deoxyparsonsianine-13-methylester|13-Me ester-12-Seco-14-deoxyparsonsianine
methyl (6aS,11R,12bS)-5,6,6a,7,9,10,11,12,12a,12b-decahydro-13-hydroxy-3-{2-[(methoxycarbonyl)oxy]ethyl}-10,12b-dimethyl-4-oxo-4H-11,1-(metheno)azuleno[4,5-a]indolizine-2-carboxylate|paxiphylline C
Ala Cys His Lys
Ala Cys Lys His
Ala Asp Pro Arg
Ala Asp Arg Pro
Ala His Cys Lys
Ala His Lys Cys
Ala Lys Cys His
Ala Lys His Cys
Ala Pro Asp Arg
Ala Pro Arg Asp
Ala Arg Asp Pro
Ala Arg Pro Asp
Cys Ala His Lys
Cys Ala Lys His
Cys His Ala Lys
Cys His Lys Ala
Cys Lys Ala His
Cys Lys His Ala
Asp Ala Pro Arg
Asp Ala Arg Pro
Asp Ile Asn Pro
Asp Ile Pro Asn
Asp Lys Pro Val
Asp Lys Val Pro
Asp Leu Asn Pro
Asp Leu Pro Asn
Asp Asn Ile Pro
Asp Asn Leu Pro
Asp Asn Pro Ile
Asp Asn Pro Leu
Asp Pro Ala Arg
Asp Pro Ile Asn
Asp Pro Lys Val
Asp Pro Leu Asn
Asp Pro Asn Ile
Asp Pro Asn Leu
Asp Pro Gln Val
Asp Pro Arg Ala
Asp Pro Val Lys
Asp Pro Val Gln
Asp Gln Pro Val
Asp Gln Val Pro
Asp Arg Ala Pro
Asp Arg Pro Ala
Asp Val Lys Pro
Asp Val Pro Lys
Asp Val Pro Gln
Asp Val Gln Pro
Glu Gly Pro Arg
Glu Gly Arg Pro
Glu Asn Pro Val
Glu Asn Val Pro
Glu Pro Gly Arg
Glu Pro Asn Val
Glu Pro Arg Gly
Glu Pro Val Asn
Glu Arg Gly Pro
Glu Arg Pro Gly
Glu Val Asn Pro
Glu Val Pro Asn
Gly Glu Pro Arg
Gly Glu Arg Pro
Gly Pro Glu Arg
Gly Pro Arg Glu
Gly Pro Val Trp
Gly Pro Trp Val
Gly Arg Glu Pro
Gly Arg Pro Glu
Gly Val Pro Trp
Gly Val Trp Pro
Gly Trp Pro Val
Gly Trp Val Pro
His Ala Cys Lys
His Ala Lys Cys
His Cys Ala Lys
His Cys Lys Ala
His Lys Ala Cys
His Lys Cys Ala
His Lys Ser Ser
His Ser Lys Ser
His Ser Ser Lys
Ile Asp Asn Pro
Ile Asp Pro Asn
Ile Asn Asp Pro
Ile Asn Pro Asp
Ile Pro Asp Asn
Ile Pro Asn Asp
Ile Pro Gln Thr
Ile Pro Thr Gln
Ile Gln Pro Thr
Ile Gln Thr Pro
Ile Thr Pro Gln
Ile Thr Gln Pro
Lys Ala Cys His
Lys Ala His Cys
Lys Cys Ala His
Lys Cys His Ala
Lys Asp Pro Val
Lys Asp Val Pro
Lys His Ala Cys
Lys His Cys Ala
Lys His Ser Ser
Lys Pro Asp Val
Lys Pro Val Asp
Lys Ser His Ser
Lys Ser Ser His
Lys Val Asp Pro
Lys Val Pro Asp
Leu Asp Asn Pro
Leu Asp Pro Asn
Leu Asn Asp Pro
Leu Asn Pro Asp
Leu Pro Asp Asn
Leu Pro Asn Asp
Leu Pro Gln Thr
Leu Pro Thr Gln
Leu Gln Pro Thr
Leu Gln Thr Pro
Leu Thr Pro Gln
Leu Thr Gln Pro
Asn Asp Ile Pro
Asn Asp Leu Pro
Asn Asp Pro Ile
Asn Asp Pro Leu
Asn Glu Pro Val
Asn Glu Val Pro
Asn Ile Asp Pro
Asn Ile Pro Asp
Asn Leu Asp Pro
Asn Leu Pro Asp
Asn Pro Asp Ile
Asn Pro Asp Leu
Asn Pro Glu Val
Asn Pro Ile Asp
Asn Pro Leu Asp
Asn Pro Val Glu
Asn Val Glu Pro
Asn Val Pro Glu
Pro Ala Asp Arg
Pro Ala Arg Asp
Pro Asp Ala Arg
Pro Asp Ile Asn
Pro Asp Lys Val
Pro Asp Leu Asn
Pro Asp Asn Ile
Pro Asp Asn Leu
Pro Asp Gln Val
Pro Asp Arg Ala
Pro Asp Val Lys
Pro Asp Val Gln
Pro Glu Gly Arg
Pro Glu Asn Val
Pro Glu Arg Gly
Pro Glu Val Asn
Pro Gly Glu Arg
Pro Gly Arg Glu
Pro Gly Val Trp
Pro Gly Trp Val
Pro Ile Asp Asn
Pro Ile Asn Asp
Pro Ile Gln Thr
Pro Ile Thr Gln
Pro Lys Asp Val
Pro Lys Val Asp
Pro Leu Asp Asn
Pro Leu Asn Asp
Pro Leu Gln Thr
Pro Leu Thr Gln
Pro Asn Asp Ile
Pro Asn Asp Leu
Pro Asn Glu Val
Pro Asn Ile Asp
Pro Asn Leu Asp
Pro Asn Val Glu
Pro Gln Asp Val
Pro Gln Ile Thr
Pro Gln Leu Thr
Pro Gln Thr Ile
Pro Gln Thr Leu
Pro Gln Val Asp
Pro Arg Ala Asp
Pro Arg Asp Ala
Pro Arg Glu Gly
Pro Arg Gly Glu
Pro Arg Ser Val
Pro Arg Val Ser
Pro Ser Arg Val
Pro Ser Val Arg
Pro Thr Ile Gln
Pro Thr Leu Gln
Pro Thr Gln Ile
Pro Thr Gln Leu
Pro Val Asp Lys
Pro Val Asp Gln
Pro Val Glu Asn
Pro Val Gly Trp
Pro Val Lys Asp
Pro Val Asn Glu
Pro Val Gln Asp
Pro Val Arg Ser
Pro Val Ser Arg
Pro Val Trp Gly
Pro Trp Gly Val
Pro Trp Val Gly
Gln Asp Pro Val
Gln Asp Val Pro
Gln Ile Pro Thr
Gln Ile Thr Pro
Gln Leu Pro Thr
Gln Leu Thr Pro
Gln Pro Asp Val
Gln Pro Ile Thr
Gln Pro Leu Thr
Gln Pro Thr Ile
Gln Pro Thr Leu
Gln Pro Val Asp
Gln Thr Ile Pro
Gln Thr Leu Pro
Gln Thr Pro Ile
Gln Thr Pro Leu
Gln Val Asp Pro
Gln Val Pro Asp
Arg Ala Asp Pro
Arg Ala Pro Asp
Arg Asp Ala Pro
Arg Asp Pro Ala
Arg Glu Gly Pro
Arg Glu Pro Gly
Arg Gly Glu Pro
Arg Gly Pro Glu
Arg Pro Ala Asp
Arg Pro Asp Ala
Arg Pro Glu Gly
Arg Pro Gly Glu
Arg Pro Ser Val
Arg Pro Val Ser
Arg Ser Pro Val
Arg Ser Val Pro
Arg Val Pro Ser
Arg Val Ser Pro
Ser His Lys Ser
Ser His Ser Lys
Ser Lys His Ser
Ser Lys Ser His
Ser Pro Arg Val
Ser Pro Val Arg
Ser Arg Pro Val
Ser Arg Val Pro
Ser Ser His Lys
Ser Ser Lys His
Ser Val Pro Arg
Ser Val Arg Pro
Thr Ile Pro Gln
Thr Ile Gln Pro
Thr Leu Pro Gln
Thr Leu Gln Pro
Thr Pro Ile Gln
Thr Pro Leu Gln
Thr Pro Gln Ile
Thr Pro Gln Leu
Thr Gln Ile Pro
Thr Gln Leu Pro
Thr Gln Pro Ile
Thr Gln Pro Leu
Val Asp Lys Pro
Val Asp Pro Lys
Val Asp Pro Gln
Val Asp Gln Pro
Val Glu Asn Pro
Val Glu Pro Asn
Val Gly Pro Trp
Val Gly Trp Pro
Val Lys Asp Pro
Val Lys Pro Asp
Val Asn Glu Pro
Val Asn Pro Glu
Val Pro Asp Lys
Val Pro Asp Gln
Val Pro Glu Asn
Val Pro Gly Trp
Val Pro Lys Asp
Val Pro Asn Glu
Val Pro Gln Asp
Val Pro Arg Ser
Val Pro Ser Arg
Val Pro Trp Gly
Val Gln Asp Pro
Val Gln Pro Asp
Val Arg Pro Ser
Val Arg Ser Pro
Val Ser Pro Arg
Val Ser Arg Pro
Val Trp Gly Pro
Val Trp Pro Gly
Trp Gly Pro Val
Trp Gly Val Pro
Trp Pro Gly Val
Trp Pro Val Gly
Trp Val Gly Pro
Trp Val Pro Gly
10,11-Dihydro-12R-hydroxy-leukotriene E4
2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one
Ormeloxifene
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
(2S)-3-amino-4-(4-tert-butylphenyl)-2-(9H-fluoren-9-ylmethoxycarbonyl)butanoic acid
3-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-hydroxybenzenemethanol (2E)-2-butenedioate
(2R)-3-amino-4-(4-tert-butylphenyl)-2-(9H-fluoren-9-ylmethoxycarbonyl)butanoic acid
GDC-0068
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Ipatasertib (GDC-0068) is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models[1][2].
7-(4-Benzylpiperazin-1-yl)-3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine
2-imino-8-methyl-5-oxo-1-(2-oxolanylmethyl)-N-(2-phenylethyl)-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxamide
6((S)-3-Benzylpiperazin-1-YL)-3-(naphthalen-2-YL)-4-(pyridin-4-YL)pyrazine
1-(2-{[(6-Amino-2-Methylpyridin-3-Yl)methyl]amino}ethyl)-6-Chloro-3-[(2,2-Difluoro-2-Pyridin-2-Ylethyl)amino]-1,4-Dihydropyrazin-2-Ol
(5S,6E,8S,10S,13R,14E,16E)-5,10,21-trihydroxy-13-methoxy-6,8,17-trimethyl-2-azabicyclo[17.3.1]tricosa-1(22),6,14,16,19(23),20-hexaene-3,12-dione
Pro-Trp-Val-Gly
A tetrapeptide composed of L-proline, L-tryptophan, L-valine, and glycine joined by peptide linkages.
3-Benzyl-4-(3-(cyclohexylmethyl)-4-methoxybenzamido)benzoic acid
4-[4-[[1-[(4-Methoxyphenyl)methyl]-5-tetrazolyl]-(3-pyridinyl)methyl]-1-piperazinyl]phenol
1-[3-[1-Cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester
5,12-Dihydroxy-6-cysteinyl-7,9,14-eicosatrienoic acid
4-[4-[[1-(2-Methylbutan-2-yl)-5-tetrazolyl]-(6-quinolinyl)methyl]-1-piperazinyl]phenol
3-(4-ethylphenyl)-4-hydroxy-4-(4-pyridin-2-ylpiperazine-1-carbonyl)-1H-quinazolin-2-one
[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
(E)-4-(dimethylamino)-N-[3-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]but-2-enamide
3-fluoro-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-cyclopentylurea
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-fluoro-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
3-fluoro-N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5S,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5R,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
2-[(3R,6aR,8S,10aR)-1-[(3-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-(2-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-(3-pyridinyl)methanone
(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-phenyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
2-aminoethyl [2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] hydrogen phosphate
vindolinium(1+)
A vinca alkaloid cation that is the conjugate acid of vindoline; major species at pH 7.3.
(12R)-hydroxy-10,11-dihydroleukotriene E4
A leukotriene with formula C23H39NO6S that results from the metabilism of leukotriene B4 by human keratinocytes.